Monday, May 11, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

The Politics of Fentanyl

Watch the election spin

Jay K Joshi by Jay K Joshi
March 26, 2024
in Politics & Law
0
The Politics of Fentanyl

Ana Pieters

The 2024 US presidential election is undoubtedly significant, and to truly grasp its implications, it is crucial to delve into the complex issue of fentanyl and its impact on American society. Over the past years, the nation has faced an alarming surge in overdose deaths caused by the synthetic opioid, leaving many communities and families devastated. Fentanyl, which was once only used within hospital settings, has now transformed into a widely available street drug, manufactured by criminal organizations, predominantly in Mexico.

The production process often involves utilizing cheap chemicals that are typically sourced from China. What makes fentanyl particularly dangerous is its frequent presence as a hidden ingredient in various illicit drugs. Consequently, unsuspecting users unknowingly consume this lethal substance, triggering fatal consequences, which in aggregate we see most apparently in the rising opioid overdose rates.

This opioid crisis has left an indelible mark on the population, fostering an atmosphere of fear, despair, and urgency. As the 2024 presidential election approaches, candidates will undoubtedly address the gravity of this issue, offering their own strategies and solutions to combat the fentanyl epidemic.

Ultimately, however, rather than safeguard the well-being of the American people, candidates will offer a spin on the fentanyl crisis that will serve their political ambitions. This is a shame, because what is good for their political careers is anything but that for the American public.
One of the most despicable tactics used by these candidates is fear-mongering. They prey on the understandable fears and concerns of the public, using exaggerated rhetoric and misinformation to manipulate their emotions. They paint a picture of chaos and danger, promising quick and easy solutions that they know will never materialize.

These candidates exploit the vulnerability of those affected by the fentanyl crisis. They offer false hope and empty promises, knowing full well that they cannot deliver on their grandiose proposals. They use the suffering of others as a means to gain sympathy, support, and ultimately votes.

This level of manipulation is not only morally reprehensible, but it has dire consequences for our fight against the fentanyl crisis. By turning the issue into a political game, these candidates distract from the real solutions and resources that are needed to address this epidemic. They prioritize their own gain over the lives of our fellow citizens, perpetuating the cycle of suffering.

Another common strategy is the use of misleading statistics and cherry-picked data. These candidates are not interested in presenting a balanced view; instead, they manipulate the information to fuel fear and push their own agendas. They rely on the public’s limited access to accurate information and use it to their advantage.

Along this vein, a common accompanying, manipulative tactic is the creation of false narratives. These candidates twist stories and manipulate events to fit their own narrative, painting themselves as saviors while disregarding the complexities of the crisis. They feed into our desire for a simple solution, offering quick fixes that are unrealistic and ineffective.

These politicians prey on the emotions of the public, appealing to our fear, anger, and sadness. They know that emotions can cloud judgment and lead us to make decisions based on impulse rather than rationality. By tapping into our vulnerabilities, they can manipulate us into supporting their policies and agendas.

These candidates often make grandiose claims about their commitment to combating the fentanyl crisis. They promise to allocate significant resources and implement comprehensive strategies. However, once in office, these promises often vanish into thin air. The urgency and dedication they displayed during their campaigns are conveniently forgotten, leaving us with hollow words and broken promises.

This is nothing more than exploiting the desperation of those affected by the crisis. They know that victims and their families yearn for solutions and are willing to grasp at any glimmer of hope. Taking advantage of this vulnerability, candidates offer hope in the form of rehabilitation programs, enforcement measures, and increased support. Yet, all too often, these promises remain unfulfilled, leaving the victims and their loved ones feeling betrayed and further disillusioned.

Perhaps most disheartening is the lack of accountability. These politicians conveniently shift blame onto others, sidestepping their own responsibility to take decisive action. They create a culture of finger-pointing and excuses, avoiding the necessary conversations and actions that could truly address the fentanyl crisis.

The sad thing about it all is that it makes for good politics and even better campaigning. That is why we can expect to see plenty of it in the coming months.

 

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Joshi is the founding editor of Daily Remedy.

Comments 0

  1. Monty Goddard says:
    2 years ago

    Truth! Disgusting truth!

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Geographic Price Dispersion as a Macro Signal: What Hospital Rate Variance Tells Investors About Regional Economic Health

    The Gross-to-Net Bubble

    0 shares
    Share 0 Tweet 0
  • The Rebate That Ate the List Price

    0 shares
    Share 0 Tweet 0
  • Transparency Without Translation

    0 shares
    Share 0 Tweet 0
  • Twenty-Eight Times Wrong

    0 shares
    Share 0 Tweet 0
  • A Two Headed Monster – State Attorneys General and the Drug Enforcement Agency

    3 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy